CCL2 and COVID-19: There is research showing that cytokines closely related to cytokine storms (IL-6, TNF-α) and chemokines such as CXCL10 and CCL2 are significantly elevated in COVID-19 patients with diabetes, indicating that these patients are more prone to excessive inflammatory responses post-infection (37).